Cassava Sciences, Inc. (SAVA)
3.26
+0.02
(+0.62%)
USD |
NASDAQ |
Dec 10, 16:00
3.265
0.00 (0.00%)
After-Hours: 20:00
Cassava Sciences Free Cash Flow: -83.91M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biogen, Inc. | 2.262B |
| Geron Corp. | -132.68M |
| Ovid Therapeutics, Inc. | -37.93M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
| Palatin Technologies, Inc. | -15.91M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.221M |
| Cash from Investing (Quarterly) | -0.08M |
| Free Cash Flow Per Share (Quarterly) | -0.1304 |
| Free Cash Flow to Equity (Quarterly) | -6.301M |
| Free Cash Flow to Firm (Quarterly) | -6.301M |
| Free Cash Flow Yield | -53.35% |